Multimodal treatment options for bilobar colorectal liver metastases

Langenbeck's Archives of Surgery

Volumn 395, Issue 6, 2010, Pages 633-641

  Homayounfar, Kia ^a   Liersch, Torsten ^a   Niessner, Martin ^a   Meller, Johannes ^a   Lorf, Thomas ^a   Becker, Heinz ^a   Ghadimi, B Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Adjuvant therapy; Multimodal treatment; Oncological strategy; Portal vein ligation; Two stage hepatectomy

Indexed keywords

BEVACIZUMAB; CARCINOEMBRYONIC ANTIBODY; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IODINE 131; IRINOTECAN; LABETUZUMAB; OXALIPLATIN;

ADULT; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SINGLE DRUG DOSE; SURGICAL MORTALITY;

AGED; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOIMMUNOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84755161025     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-010-0604-7     Document Type: Article

References (27)

1. Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13: 1271-1280
2. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818-827
3. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703-710
4. Shimada H, Tanaka K, Matsuo K, Togo S (2006) Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbeck's Arch Surg 391:130-142
5. Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14:ii13-ii16 (Pubitemid 36874133)
6. Folprecht G, Gruenberger T, Hartmann JT, Lordick F, Stoehlmacher J, Bechstein W, Ockert D, Herrmann T, Liersch T, Koehne CH (2010) Cetuximab plus FOLFOX6 or cetuximab plus FOLFIRI as neoadjuvant treatment of nonresectable colorectal liver metastases: a randomized multicenter study (CELIM-study). Lancet Oncol 11:38-47
7. Homayounfar K, Liersch T, Schuetze G, Niessner M, Goralczyk AD, Meller J, Langer C, Ghadimi BM, Becker H, Lorf T (2009) Two-stage hepatectomy (R0) with portal vein ligation-towards curing patients with extended bilobar colorectal liver metastases. Int J Colorectal Dis 24:409-418
8. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P (2004) A 2-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037-1051
9. NikfarjamM, Shereef S, Kimchi ET, GusaniNJ, Jiang Y, Avella DM, Mahraj RP, Staveley-O'Carroll KF (2009) Survival outcomes of patients with colorectal liver metastases following hepatic resection or ablation in the era of effective chemotherapy. Ann Surg Oncol 16:1860-1867
10. Liersch T,Meller J,Kulle B, Behr TM,Markus P, Langer C,Ghadimi BM,WegenerWA, Kovacs J, Horak ID, Becker H, Goldenberg DM (2005) Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol 23:6763-6770
11. Liersch T, Meller J, Bittrich M, Kulle B, Becker H, Goldenberg DM (2007) Update of carcinoembryonic antigen radioimmunotherapy with (131)I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann Surg Oncol 14:2577-2590
12. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216 (Pubitemid 30099779)
13. Truant S, Oberlin O, Sergent G, Lebuffe G, Gambiez L, Ernst O, Pruvot FR (2007) Remnant liver volume to body weight ratio >0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver. J Am Coll Surg 204:22-33
14. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824-829
15. Schmiegel W, Pox C, Adler G, Fleig W, Folsch UR, Fruhmorgen P, Graeven U, Hohenberger W, Holstege A, Junginger T, Kühlbacher T, Porschen R, Propping P, Riemann JF, Sauer R, Sauerbruch T, Schmoll HJ, Zeitz M, Selbmann HK (2004) S3- Guidelines conference "Colorectal Carcinoma" 2004. Z Gastroenterol 42:1129-1177
16. Folprecht G, Grothey A, Alberts S, Raab HR, Koehne CH (2005) Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16:1311-1319
17. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B (2009) Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases. Ann Surg Oncol 16:1202-1207
18. Wicherts DA, Miller R, de Haas RJ, Bitsakou G, Vibert E, Veilhan LA (2008) Long-term results of 2-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248: 994-1005
19. Lygidakis NJ, Bhagat AD, Vrachnos P, Grigorakos L (2007) Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases-newer multimodality approach. Hepatogastroenterology 54:1020-1024
20. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Takahashi T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267-272
21. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC (2008) Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol 15:1908-1917
22. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-1016
23. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL, Miller LL (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343:905-914
24. HurwitzH, Fehrenbacher L,NovotnyW, Cartwright T, Hainsworth J, HeimW, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335-2342
25. Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJM, Erdkamp SJG, FL VAH, van Groeningen CJ, Sinnige HA, Richel DJ, Voest EE, Dijkstra JR, Vink-Börger ME, Antonini NF, Mol L, van Krieken JH, Dalesio O, Punt CJ (2009) Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med 360:563-572
26. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, Belghiti J, Piedbois P, Guimbaud R, Nordlinger B, Bugat R, Lazorthes F, Bedenne L (2006) Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 24:4976-4982
27. Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R, Garden OJ, Blumgart LH, Fong Y (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204:753-761